Is There a Paradox of FFR Outcomes in Diabetic Patients?
Highlights
- • There was a significant and stepwise decrease in the incidence of the primary endpoint in diabetic patients by FFR groups which was not seen in the non-diabetic patients.
- • FFR for diabetic patients predicted an increased risk of death and target vessel MI but not TVR.
- • Whether FFR thresholds should change for patients with acute coronary syndrome patients, microvascular disease, or congestive heart failure remains a subject for future studies.